DEREK WRZESINSKI: Open Payments
NPI 1285282731 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 27 payments from 13 companies in 2025. Trend: 2023 $1,181 · 2024 $522 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $152 |
| Dexcom, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Exact Sciences Corporation | 3 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| ABBVIE INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: JARDIANCE, Dexcom G6 Transmitter, TRELEGY ELLIPTA, Cologuard Collection Kit, UBRELVY, AIRSUPRA, ELIQUIS, Heplisav-B.
Industry payments across TX — which companies pay providers there.
